1. Home
  2. FLGT vs GAU Comparison

FLGT vs GAU Comparison

Compare FLGT & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • GAU
  • Stock Information
  • Founded
  • FLGT 2011
  • GAU 1999
  • Country
  • FLGT United States
  • GAU Canada
  • Employees
  • FLGT N/A
  • GAU N/A
  • Industry
  • FLGT Medical Specialities
  • GAU
  • Sector
  • FLGT Health Care
  • GAU
  • Exchange
  • FLGT Nasdaq
  • GAU Nasdaq
  • Market Cap
  • FLGT 697.3M
  • GAU 731.5M
  • IPO Year
  • FLGT 2016
  • GAU N/A
  • Fundamental
  • Price
  • FLGT $22.51
  • GAU $2.86
  • Analyst Decision
  • FLGT Buy
  • GAU Strong Buy
  • Analyst Count
  • FLGT 3
  • GAU 2
  • Target Price
  • FLGT $25.33
  • GAU $3.00
  • AVG Volume (30 Days)
  • FLGT 218.2K
  • GAU 3.6M
  • Earning Date
  • FLGT 11-07-2025
  • GAU 11-06-2025
  • Dividend Yield
  • FLGT N/A
  • GAU N/A
  • EPS Growth
  • FLGT N/A
  • GAU N/A
  • EPS
  • FLGT N/A
  • GAU N/A
  • Revenue
  • FLGT $303,223,000.00
  • GAU $309,575,000.00
  • Revenue This Year
  • FLGT $15.19
  • GAU $80.41
  • Revenue Next Year
  • FLGT $10.58
  • GAU $43.45
  • P/E Ratio
  • FLGT N/A
  • GAU N/A
  • Revenue Growth
  • FLGT 4.31
  • GAU 223.63
  • 52 Week Low
  • FLGT $14.57
  • GAU $1.00
  • 52 Week High
  • FLGT $23.57
  • GAU $2.92
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 53.81
  • GAU 69.25
  • Support Level
  • FLGT $22.09
  • GAU $2.13
  • Resistance Level
  • FLGT $23.09
  • GAU $2.92
  • Average True Range (ATR)
  • FLGT 0.65
  • GAU 0.15
  • MACD
  • FLGT -0.09
  • GAU 0.04
  • Stochastic Oscillator
  • FLGT 41.99
  • GAU 92.41

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About GAU Galiano Gold Inc.

Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.

Share on Social Networks: